26.10.22
Cannabis Wealth
Michael Sassano, CEO of SOMAÍ Pharmaceuticals Unipessoal LDA, shares his thoughts on recreational cannabis reform in Germany.
Leaks of the long-awaited first draft of Germany’s recreational cannabis reform have set the EU cannabis industry abuzz with just a few bullet points from the German Health Ministries Narcotic Drug Commissioner Burkard Blienert’s desk.
18.10.22
Talk Markets
The third quarter for European cannabis was painfully slow and uneventful. What started as an exciting, promising year fizzled into typical summer laziness. It seems there is even less to be excited about on the horizon and many rumors swirl around Germany’s upcoming adult-use legalization. Although some quarters are less optimistic than others, the European Union cannabis market is long-term bullish and still on track to be the second-largest market in the world. And one thing is for sure, there is more European cannabis infrastructure needed, capital is critical to the growth, and early adopters are leading the largest M&A deals.
12.10.22
Forbes
You’d be amazed how many people want to be entrepreneurs. You’d be even more amazed to learn this enthusiasm exists across all age groups. In fact, according to one study1, one in four over the age of 65 possess an “entrepreneurial intention,” while nearly one in five the age of 50 feel the same.
12.10.22
Benzinga
Is the American cannabis sector facing the prospect of just a few players dominating the market? While worries abound in some corners of the space, sources say that is not the current case.
02.10.22
CBD Health Podcast with Dr. Thomas Rocco
Listen to Michael Sassano who is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States. Currently he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products. Dr Thomas Rocco is a Medical Director of a medical marijuana evaluation center licensed by the Rhode Island Department of Health and physician at BAK 2 Basics CBD Medical Consultants.
30.09.22
Let’s be Blunt
On this episode of Let’s be Blunt, Montel talks with Michael Sassano, CEO of Somai Pharmaceuticals, a large-scale manufacturer of medical canna compounds based in Portugal. His experience as both a developer and banker in the United States and Europe provides a unique perspective towards navigating international rules and regulations for developing canna medicines.
#portugal #cannabiscommunity #cannabisculture
Queens On A Roll
This podcast was created to educate & inspire people about the ably different…
Listen on: Apple Podcasts Spotify
30.09.22
TheCelebrity.Online
Michael Sassano is the founder, chairman and CEO of Somai Pharmaceuticals. Michael Sassano is also an invester and expert in the fields of Cannabis and herbal medicine.
TheCelebrity.Online has recently interviewed Mr. Michael Sassano for his expert opnion about his industry and some more aspects of his life and success. Below is the question and answer session of Michael Sassano with TheCelebrity.Online.
About Micheal Sassano’s Business – The business of building cannabis facilities, operating them and expanding throughout states and now countries has been a great creative journey. Not just for treating buildings but working through complex chemistry to be quality products that people want and that help them with whatever they need it for.
28.09.22
Ganjapreneur
In less than a decade, the cannabis industry has gone from seeing a worldwide blanket prohibition of the plant to today, where new and exciting cannabis opportunities can be found across the globe.
As you read this, cannabis flower is soaring from country to country. That’s right — cannabis is a global market breaking through borders. As expected, lower-cost-producing countries and regions are fast becoming the go-to suppliers for higher-cost, wealthier zones. Globally, what was discussed for years is coming to fruition. Let’s consider the state of the six major worldwide cannabis growing markets: the United States, Canada, South America, Europe, Africa, Australia, and Asia.
26.09.22
SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal.